Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID ‐19 pandemic
Journal of Viral Hepatitis · 2024
DOI: 10.1111/jvh.13983 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Viral Hepatitis, 2024. Verfasst von Maria Paola Tramonti Fantozzi und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19, Hepatitis C, Pandemics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
HCV infection poses a global health threat, with significant morbidity and mortality. This study examines HCV trends in a large Italian region from 2015 to 2022, considering demographic changes, evolving clinical profiles, treatment regimens and outcomes, including the impact of the COVID‐19 pandemic. This multicentre retrospective study analysed demographics, clinical histories and risk factors in 6882 HCV patients. The study spanned before and after the direct‐acting antiviral (DAA) era, and the COVID‐19 period, focusing on treatment outcomes (SVR12, non‐SVR12 and patients lost to follow‐up). Statistical methods included ANOVA, multinomial logistic regression, Kruskal–Wallis test and chi‐square analysis, and were conducted adhering to the intention‐to‐treat (ITT) principle. The cohort, mainly Italian males (average age 58.88), showed Genotype 1 dominance (56.6%) and a high SVR12 rate (97.5%). The pandemic increased follow‐up losses, yet SVR12 rates remained stable, influenced by factors like age, gender, cirrhosis and comorbidities. Despite COVID‐19 challenges, the region sustained high SVR12 rates in HCV care, emphasising the importance of sustained efforts in HCV care. Continuous screening and targeted interventions in high‐risk populations are crucial for achieving WHO elimination targets. The study highlights the resilience of HCV care during the pandemic and provides insights for future public health strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
- Sant'Anna School of Advanced Studies, Pisa, Italy.
- Hepatology Unit, Pisa University Hospital, Pisa, Italy.
- CRIA-MASVE Center for Research and Innovation, Careggi University Hospital, Florence, Italy.
- AUSL Toscana Sud Est, Grosseto Hospital, Grosseto, Italy.
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
ORCID-Profile: Maria Paola Tramonti Fantozzi, Erica De Vita, Cristina Stasi, Massimiliano Fabbiani, Anna Linda Zignego, Lara Tavoschi
Zitieren
APA
Tramonti Fantozzi, M. P., Ceccarelli, L., Petri, D., De Vita, E., Agostini, A., Colombatto, P., Stasi, C., Rossetti, B., Brunetto, M., Surace, L., Salvati, A., Calì, A., Tacconi, D., Bianco, C., Redi, D., Fabbiani, M., Panza, F., Luchi, S., Modica, S., …, & Tavoschi, L. (2024). Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID ‐19 pandemic. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13983
Vancouver
Tramonti Fantozzi MP, Ceccarelli L, Petri D, De Vita E, Agostini A, Colombatto P, et al. Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID ‐19 pandemic. Journal of Viral Hepatitis. 2024. doi:10.1111/jvh.13983
BibTeX
@article{TramontiFantozzi2024,
author = {Tramonti Fantozzi, Maria Paola and Ceccarelli, Luca and Petri, Davide and De Vita, Erica and Agostini, Antonello and Colombatto, Piero and Stasi, Cristina and Rossetti, Barbara and Brunetto, Maurizia and Surace, Lidia and Salvati, Antonio and Calì, Alessia and Tacconi, Danilo and Bianco, Claudia and Redi, David and Fabbiani, Massimiliano and Panza, Francesca and Luchi, Sauro and Modica, Sara and Moneta, Sara and Iacopini, Sarah and Nencioni, Cesira and Chigiotti, Silvia and Ottaviano, Giulia and Zignego, Anna Linda and Blanc, Pierluigi and Pierotti, Piera and Mariabelli, Elisa and Berni, Roberto and Silvestri, Caterina and Tavoschi, Lara},
title = {Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID ‐19 pandemic},
journal = {Journal of Viral Hepatitis},
year = {2024},
doi = {10.1111/jvh.13983}
}
EUVIMED